CHU de Quebec-Universite Laval
187
31
54
85
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.0%
13 terminated/withdrawn out of 187 trials
86.7%
+0.2% vs industry average
13%
24 trials in Phase 3/4
12%
10 of 85 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (187)
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Role: lead
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Role: collaborator
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)
Role: collaborator
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
Role: collaborator
Optimizing Patient-centred Outcomes Using Opioid Minimization Strategies: The OPUS Anesthesia Pilot Trial
Role: lead
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
Role: lead
OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
Role: lead
Efficacy of High Intensity Laser for Provoked Vestibulodynia
Role: collaborator
Efficacy of Dry Needling in Reducing Pain During Sexual Intercourse
Role: collaborator
Self-questionnaire in Osteoporosis
Role: lead
Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
Role: collaborator
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
Role: collaborator
Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis
Role: lead
Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
Role: lead
Angiomammography and Neoadjuvant Chemotherapy
Role: lead
Screening Contrast-enhanced Mammography
Role: lead
Paravertebral Block for Mastectomy With Immediate Reconstruction
Role: lead
Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa
Role: lead
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Role: lead
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Role: lead